---

The efficacy and safety of Short course therapy with Cefixime in URTI in Indian Scenario

---

Original Article

Author Details : Ketan Pakhale, G K Tandon, Tanma Bansal, Vineet Jain, Dhiraj Dhoot*

Volume : 3, Issue : 3, Year : 2020

Article Page : 81-85

https://doi.org/10.18231/j.ijoas.2020.018

Suggest article by email

Get Permission

---

Abstract

Upper respiratory tract infections (URTI) are one of the commonest cause for a patient’s visit to outpatient department (OPD). Short course therapies with penicillin and cephalosporin class of antibiotics are commonly prescribed in URTI cases. This study was a retrospective, multicentre, observational cohort analysis, planned to evaluate the effectiveness and safety of Cefixime 400 mg per day in patients of URTI, using WURSS 21 score. We analysed the data of 200 patients who were prescribed Cefixime for URTI. Most of the patients (55%) were male. The baseline mean WURSS score of 41.09 33.45 decreased to 25.74 22.29 [(-37.3%), p value<0> patients reported adverse effects. The findings of the present survey confirm the effectiveness and safety of short course of Cefixime therapy in URTI.

Keywords: URTI, Cefixime, WURSS, India.

How to cite : Pakhale K, Tandon G K, Bansal T, Jain V, Dhoot D, The efficacy and safety of Short course therapy with Cefixime in URTI in Indian Scenario. J Otorhinolaryngol Allied Sci 2020;3(3):81-85

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.